ArticleScientific reports2024
A precise model for skin cancer diagnosis using hybrid U-Net and improved MobileNet-V3 with hyperparameters optimization.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- An Attention-Residual Hybrid CNN for CT-Based Multiclass Classification of Alcohol-Related Liver Disease: Differential Diagnosis Against HBV-Related Cirrhosis.Diagnostics (Basel, Switzerland) · 2026Article
- Bayesian hyperparameter optimization improves scGPT fine-tuning for single-cell multi-omics integration.Bioinformatics (Oxford, England) · 2026Article
- A cascaded detection method for railway foreign object intrusion in extreme weather based on improved LR-ASPP and fused Mamba-YOLO.Scientific reports · 2026Article
- Article
- Explainable deep learning ensemble framework for accurate classification of wild poisonous mushroom species.BMC biotechnology · 2025Article
- Advancing skin cancer diagnosis with deep learning and attention mechanisms.Scientific reports · 2025Article
- Audio Deepfake Detection via a Fuzzy Dual-Path Time-Frequency Attention Network.Sensors (Basel, Switzerland) · 2025Article
- Novel nomogram and decision curve analysis for predicting head and neck skin cancer risk.Scientific reports · 2025Article
- Enhanced skin cancer classification using modified efficientNetV2L with adaptive early stopping mechanism.Scientific reports · 2025Article
- Visual prediction method based on time series-driven LSTM model.Scientific reports · 2025Article
- A dual-stream deep learning framework for skin cancer classification using histopathological-inherited and vision-based feature extraction.Scientific reports · 2025Article
- Deep Ensemble Learning for Multiclass Skin Lesion Classification.Bioengineering (Basel, Switzerland) · 2025Article
- Automatic melanoma detection using an optimized five-stream convolutional neural network.Scientific reports · 2025Article
- SkinEHDLF a hybrid deep learning approach for accurate skin cancer classification in complex systems.Scientific reports · 2025Article
- Design and Implementation of ESP32-Based Edge Computing for Object Detection.Sensors (Basel, Switzerland) · 2025Article
- The segmentation of nanoparticles with a novel approach of HRUScientific reports · 2025Article
- Global burden of skin cancer and its subtypes: a comprehensive analysis from 1990 to 2021 with projections to 2040.Frontiers in public health · 2025Article
- LMS-ViT: a multi-scale vision transformer approach for real-time smartphone-based skin cancer detection.Frontiers in artificial intelligence · 2025Article
- Intelligence model on sequence-based prediction of PPI using AISSO deep concept with hyperparameter tuning process.Scientific reports · 2024Article
- Enhanced skin cancer diagnosis: a deep feature extraction-based framework for the multi-classification of skin cancer utilizing dermoscopy images.Frontiers in medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer is a frequently occurring and possibly deadly disease that necessitates prompt and precise diagnosis in order to ensure efficacious treatment. This paper introduces an innovative approach for accurately identifying skin cancer by utilizing Convolution Neural Network architecture and optimizing hyperparameters. The proposed approach aims to increase the precision and efficacy of skin cancer recognition and consequently enhance patients' experiences. This investigation aims to tackle various significant challenges in skin cancer recognition, encompassing feature extraction, model architecture design, and optimizing hyperparameters. The proposed model utilizes advanced deep-learning methodologies to extract complex features and patterns from skin cancer images. We enhance the learning procedure of deep learning by integrating Standard U-Net and Improved MobileNet-V3 with optimization techniques, allowing the model to differentiate malignant and benign skin cancers. Also substituted the crossed-entropy loss function of the Mobilenet-v3 mathematical framework with a bias loss function to enhance the accuracy. The model's squeeze and excitation component was replaced with the practical channel attention component to achieve parameter reduction. Integrating cross-layer connections among Mobile modules has been proposed to leverage synthetic features effectively. The dilated convolutions were incorporated into the model to enhance the receptive field. The optimization of hyperparameters is of utmost importance in improving the efficiency of deep learning models. To fine-tune the model's hyperparameter, we employ sophisticated optimization methods such as the Bayesian optimization method using pre-trained CNN architecture MobileNet-V3. The proposed model is compared with existing models, i.e., MobileNet, VGG-16, MobileNet-V2, Resnet-152v2 and VGG-19 on the "HAM-10000 Melanoma Skin Cancer dataset". The empirical findings illustrate that the proposed optimized hybrid MobileNet-V3 model outperforms existing skin cancer detection and segmentation techniques based on high precision of 97.84%, sensitivity of 96.35%, accuracy of 98.86% and specificity of 97.32%. The enhanced performance of this research resulted in timelier and more precise diagnoses, potentially contributing to life-saving outcomes and mitigating healthcare expenditures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.